Research dating back 20 years has demonstrated the involvement of pro-inflammatory cytokine IL-1β in AD pathogenesis, with effects ranging from activation of microglia and astrocytes to inhibition of LTP [31,32,33,34,35]. Here, IL1B is linked to Alzheimer disease.